Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

Clinical trial NCT00501735 · COMPLETED

Trial details

NCT number: NCT00501735
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma (CTCL),

Start date: 2007-07-01
Primary completion: 2010-07-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.